Indivior PLC Logo

Indivior PLC

INDV | IL

Overview

Corporate Details

ISIN(s):
GB00BN4HT335 (+1 more)
LEI:
213800V3NCQTY7IED471
Country:
United Kingdom
Address:
234 BATH ROAD, SL1 4EE SLOUGH
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Indivior PLC is a global pharmaceutical company specializing in the development, manufacturing, and commercialization of medicines to treat substance use disorders (SUD), addiction, and other serious mental illnesses. The company is a key player in pioneering treatments for opioid use disorder (OUD). Its research and development activities are focused on creating life-transforming therapies for patients with addiction and behavioral health issues. Established as a division of Reckitt Benckiser, Indivior demerged to become an independent company in December 2014.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Indivior PLC. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-24 16:52
Major Shareholding Notification
Holding(s) in Company
English 23.4 KB
2025-07-24 09:34
Major Shareholding Notification
Holding(s) in Company
English 25.1 KB
2025-07-23 09:08
Major Shareholding Notification
Holding(s) in Company
English 25.1 KB
2025-07-21 17:23
Major Shareholding Notification
Holding(s) in Company
English 25.1 KB
2025-07-21 09:33
Major Shareholding Notification
Holding(s) in Company
English 25.1 KB
2025-07-18 09:35
Major Shareholding Notification
Holding(s) in Company
English 25.2 KB
2025-07-17 15:00
Report Publication Announcement
Notice of Results
English 10.6 KB
2025-07-01 09:43
Major Shareholding Notification
Holding(s) in Company
English 56.2 KB
2025-07-01 08:49
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
English 4.8 KB
2025-06-30 08:00
Regulatory News Service
Indivior Announces Inclusion in US Russell Indexes
English 12.9 KB
2025-06-25 08:00
Board/Management Information
Indivior Appoints Tony Kingsley to the Board
English 14.0 KB
2025-06-17 17:42
Major Shareholding Notification
Holding(s) in Company
English 26.7 KB
2025-06-13 09:10
Director's Dealing
Director/PDMR Shareholding - Correction
English 28.2 KB
2025-06-12 17:24
Director's Dealing
Director/PDMR Shareholding
English 26.9 KB
2025-06-10 17:12
Major Shareholding Notification
Holding(s) in Company
English 26.8 KB

Automate Your Workflow. Get a real-time feed of all Indivior PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Indivior PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Swedish Orphan Biovitrum Logo
Develops innovative therapies for rare diseases in haematology, immunology, and specialty care.
Sweden SOBI
SymBio Pharmaceuticals Limited Logo Japan 4582
Synbiotic SE Logo
A vertically integrated European group for the entire hemp and cannabis value chain.
Germany SBX
Synektik S.A. Logo
Radiopharmaceuticals, medical devices & IT solutions for oncology, cardiology, and neurology.
Poland SNT
Synthaverse S.A. Logo
Develops and sells oncology, hematology, and immunology drugs and vaccines globally.
Poland BML
TAIKO PHARMACEUTICAL CO., LTD. Logo Japan 4574
Takeda Pharmaceutical Company Limited Logo Japan 4502
TAUNS Laboratories, Inc. Logo Japan 197A
Tchaikapharma High Quality Medicines AD Logo
Manufactures affordable generic & complex polypill medicines for socially significant diseases.
Bulgaria THQM
Teva Pharmaceutical Industries Ltd. Logo
A global leader in generic drugs and innovative medicines for CNS and immuno-oncology.
Israel TEVA